![D. Kirkpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
D. Kirkpatrick
Chief Executive Officer at
ENSYSCE BIOSCIENCES, INC.
Net worth: 27 $ as of 30/07/2026
Profile
D.
Lynn Kirkpatrick was the founder of ProlX Pharmaceuticals Corp., founded in 1999, serving as President & Chief Executive Officer from 1999 to 2006.
Dr. Kirkpatrick is the founder of Phusis Therapeutics, Inc., founded in 2009.
The current job is Chief Executive Officer & Director at Ensysce Biosciences, Inc., starting in 2026.
Former jobs include President, Chief Executive Officer & Director at Ensysce Biosciences, Inc.; Director at BiologicsMD, Inc.; Chief Scientific Officer at Biomira, Inc.; Professor at the University of Regina from 1983 to 2001; and Chief Scientific Officer at Cascadian Therapeutics LLC from 2006 to 2008.
Education includes undergraduate and doctorate degrees from the University of Saskatchewan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/11/2025 | 107 ( 0% ) | 27 $ | 30/07/2026 |
D. Kirkpatrick active positions
| Companies | Position | Start |
|---|---|---|
| ENSYSCE BIOSCIENCES, INC. | Chief Executive Officer | 31/12/2008 |
Former positions of D. Kirkpatrick
| Companies | Position | End |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Chief Tech/Sci/R&D Officer | 30/12/2008 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Chief Tech/Sci/R&D Officer | 10/12/2007 |
ProlX Pharmaceuticals Corp.
 ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Chief Executive Officer | 31/12/2005 |
University of Regina
 University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/12/2000 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Founder | - |
Training of D. Kirkpatrick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Health Services |
University of Regina
University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
BiologicsMD, Inc.
 BiologicsMD, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical therapeutic development company which focuses on smart therapies for hair loss and bone disorders | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProlX Pharmaceuticals Corp.
ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Health Technology |
Ensysce Biosciences, Inc. /Old/
 Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Supplies drugs for pain and cancer markets | Distribution Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
Ensysce Biosciences, Inc.
 Ensysce Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
- Stock Market
- Insiders
- D. Kirkpatrick
